Cas:1181083-20-4 (3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride manufacturer & supplier

We serve Chemical Name:(3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride CAS:1181083-20-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride

Chemical Name:(3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride
CAS.NO:1181083-20-4
Synonyms:(R)-3-(Diethylamino)pyrrolidine dihydrochloride;(R)-N,N-Diethylpyrrolidin-3-amine dihydrochloride
Molecular Formula:C8H20Cl2N2
Molecular Weight:215.16400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:15.27000
Exact Mass:214.10000
LogP:2.62290

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (R)-3-(Diethylamino)pyrrolidine dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-N,N-Diethylpyrrolidin-3-amine dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-3-(Diethylamino)pyrrolidine dihydrochloride Use and application,(R)-3-(Diethylamino)pyrrolidine dihydrochloride technical grade,usp/ep/jp grade.


Related News: It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. (3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride manufacturer Amanpour is based in London, and said she feels fortunate to have health insurance through work and incredible doctors who are treating me in a country underpinned by, of course, the brilliant NHS [National Health Service],” CNN reported.
“I want to applaud Christiane Amanpour for her candor, bravery and always working towards the greater good,” he said in a statement. “As a cancer survivor, I too encourage people to listen to their bodies and get all early cancer screenings available to them. (3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride supplier The vaccine also proved safe during the two-year trial, in which eleven doses were administered to randomly chosen patients with mild dementia. People who received the vaccine, known as AADvac1, experienced about the same numbers of side effects and adverse events as those who were given a placebo. (3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride vendor It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. (3R)-N,N-diethylpyrrolidin-3-amine,dihydrochloride factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.